- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:22 | CLARITY PHARMACEUTICALS LTD: Notification regarding unquoted securities - CU6 | - | ASX | ||
| 02:05 | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 01:26 | CYCLOPHARM LIMITED: Final Director's Interest Notice - JW | - | ASX | ||
| 01:24 | CYCLOPHARM LIMITED: Resignation of Non-Executive Director John Wigglesworth | - | ASX | ||
| 01:10 | PEAK PROCESSING LIMITED: Correspondence received from former CEO | - | ASX | ||
| 00:41 | MAYNE PHARMA GROUP LIMITED: MYX expects no material impact from US s232 tariffs | - | ASX | ||
| Mo | Avicanna Inc: Avicanna appoints Kilic as director | 1 | Stockwatch | ||
| Mo | AMPLIA THERAPEUTICS LIMITED: Amplia Therapeutics Halts Recruitment in AMPLICITY Trial | 1 | ASX | ||
| Mo | Avicanna Inc.: Avicanna Announces Changes to its Board of Directors | 1 | GlobeNewswire (USA) | ||
| Mo | Tapestry beruft Pinterest-CTO Matt Madrigal in den Verwaltungsrat | 3 | Investing.com Deutsch | ||
| Mo | Tapestry appoints Pinterest CTO Matt Madrigal to board | 2 | Investing.com | ||
| Mo | NUTRA PHARMA CORP - 10-Q, Quarterly Report | - | SEC Filings | ||
| Mo | Vireo Growth Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mo | LB PHARMACEUTICALS INC - S-1, General form for registration of securities | - | SEC Filings | ||
| Mo | Takeda tears up Denali partnership, returning dementia asset amid restructuring | 4 | FierceBiotech | ||
| Mo | Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why | 4 | Benzinga.com | ||
| Mo | Innocan Pharma Corp (2): Innocan closes $200,000 (U.S.) debenture offering | 12 | Stockwatch | ||
| Mo | How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval | 6 | Zacks | ||
| Mo | Simply Solventless Concentrates Ltd: Simply Solventless receives OK for DIP financing, SISP | 3 | Stockwatch | ||
| Mo | FDA floats new clinical trial reforms; Takeda punts Denali brain drug | 6 | BioPharma Dive |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
 | NOVO NORDISK | 4 | 40 | -0,09 % | Was steckt dahinter?: Novo Nordisk: Adipositas-Medikament jetzt mit Abo und satten Einsparungen | © Foto: Christian Schultz/dpaNovo Nordisk startet eine neue Strategie gegen Eli Lilly - mit hohen Einsparungen für Patienten.Der dänische Pharmariese Novo Nordisk führt in den USA ein Abonnementmodell... ► Artikel lesen | |
| BAYER | 4 | 36 | 0,00 % | Ihre wichtigsten Termine: Alle Blicke auf: Bayer, Deutsche Telekom, Hewlett Packard Enterprise & Clariant | © Foto: Bernd von Jutrczenka - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | ||
| AKARI THERAPEUTICS | 4 | - | -20,13 % | XFRA NEW INSTRUMENTS AVAILABLE ON 31.03.2026 | The following instruments on XETRA do have their first trading 31.03.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 31.03.2026
Aktien
1 SE0009697204 Boho Group AB
2 SE0008321608... ► Artikel lesen | ||
| VERTICAL AEROSPACE | 4 | - | -0,51 % | Vertical Aerospace Achieves Historic Piloted Thrustborne Transition | Industry first under strict oversight of the UK Civil Aviation Authority (CAA), which is working in close collaboration with the European Union Aviation Safety Agency (EASA) toward certification... ► Artikel lesen | ||
| ELI LILLY | 3 | 125 | -0,05 % | Firma fordert Preiserhöhungen: Was steckt hinter Eli Lillys möglichen Investitionspause? | © Foto: Sascha Lotz/dpaEli Lilly fordert von Großbritannien Preiserhöhungen und das Ende des Rabattprogramms, andernfalls werden Investitionen in Forschung und Produktion gestoppt.Eli Lilly fordert... ► Artikel lesen | ||
| OPUS GENETICS | 3 | 2 | -1,78 % | Opus Genetics, Inc.: Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital | - Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment -- Strategic financing to accelerate development of earlier-stage... ► Artikel lesen | ||
| INNOCAN PHARMA | 3 | 2 | +1,46 % | Innocan Pharma Corporation: Innocan Pharma Announces Closing of Additional Debenture | The Debenture will bear interest at the rate of 10% per annum and matures at the earlier of: (i) 12 months from the date of issuance; and (ii) the completion of the Company's previously announced proposed... ► Artikel lesen | ||
| ASSEMBLY BIOSCIENCES | 3 | - | -1,98 % | Assembly Biosciences und der 40-Milliarden-Dollar-Markt - Übernahme-Rallye voraus? | Die Aktie von Assembly Biosciences gehört derzeit zu den auffälligsten Diskrepanzen zwischen wissenschaftlichem Potenzial und Börsenbewertung im Biotechnologiesektor. Während das Unternehmen an neuartigen... ► Artikel lesen | ||
| AVALO THERAPEUTICS | 3 | - | -2,87 % | This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday | |||
| ABBVIE | 2 | 55 | -0,33 % | How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales? |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| SCHOTT PHARMA AG & CO KGAA | 13,700 | 18,70 | +36 % | 3 | 11 | - | |||
| DOCMORRIS AG | 5,430 | 7,37 | +36 % | 5 | 8 | 4 | |||
| MERCK KGAA | 109,80 | 141,60 | +29 % | 12 | 8 | - | |||
| ELI LILLY AND COMPANY | 811,00 | 968,78 | +19 % | 1 | - | - | |||
| NOVO NORDISK A/S | 31,930 | 37,47 | +17 % | 16 | 31 | 3 | ||
| SANOFI SA | 83,32 | 94,57 | +14 % | 10 | 18 | - | |||
| ASTRAZENECA PLC | 175,55 | 191,96 | +9 % | 26 | 1 | 7 | |||
| BAYER AG | 39,695 | 41,71 | +5 % | 27 | 11 | 1 | |||
| PFIZER INC | 24,510 | 23,93 | -2 % | 1 | 5 | - | |||
| NOVARTIS AG | 133,58 | 129,80 | -3 % | 6 | 14 | 4 | |||
| GSK PLC | 24,550 | 22,79 | -7 % | 5 | 11 | 16 | |||
| DERMAPHARM HOLDING SE | 47,250 | 34 | -28 % | - | 2 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.